MedTech News
.................... by Andrew Celentano
J&J launches IVL device in Europe; Medtronic looks at pacing for more patients
J&J’s Shockwave Javelin intravascular lithotripsy catheter treats people with peripheral artery disease.
Genetic test predicts response to weight-loss drugs
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s.
Menopause drug reduces hot flashes by more than 70%, international clinical trial finds
The investigational drug elinzanetant significantly reduces hot flashes and night sweats for postmenopausal women, a large, international clinical trial has found.
Digital cell twin opens up new avenues in lung cancer research
A team led by Christian Baumgartner of the Institute of Health Care Engineering at Graz University of Technology (TU Graz) has developed a highly detailed digital twin of the A549 lung cancer cell line. The twin builds on bioelectric processes and calcium dynamics in the cell interior in innovative new ways.
One-time gene therapy could end lifelong transfusions for rare blood disease
Thanks to in-utero blood transfusion technology, what was once a fatal diagnosis in the womb can now result in live births. However, this medical advancement created a new challenge: a growing population of children born with that diagnosis—the severe, inherited blood disorder alpha thalassemia—which requires lifelong specialized care.
AI model offers accurate and explainable insights to support autism assessment
Scientists have developed and tested a deep-learning model that could support clinicians by providing accurate results and clear, explainable insights—including a model-estimated probability score for autism.
Shape-shifting material could transform future of implantable and ingestible medical devices
Researchers led by Rice University’s Yong Lin Kong have developed a soft but strong metamaterial that can be controlled remotely to rapidly transform its size and shape.
Scientists discover powerful new antibiotic class to tackle deadly superbugs
Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity against some of the world’s most dangerous multidrug-resistant (MDR) bacteria.